CD53 and neoplasm: Immunotherapy is an effective alternative treatment strategy to gene and chemotherapies, where tumor cells residing beyond the resection cavity can be targeted without damaging the healthy normal brain tissue, by transferring anti-glioblastoma adoptive T lymphocytes toward a selective tumor cell-surface antigen [129].